US 8119631
Inhibitors of interleukin-1β converting enzyme
granted A61KA61K38/00A61P
Quick answer
US patent 8119631 (Inhibitors of interleukin-1β converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04